Improving the use of proton pump inhibitors through pharmacist education

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates whether a pharmacist-led educational intervention can effectively reduce the inappropriate use of proton pump inhibitors (PPIs) among adult patients in Ras Al Khaimah. Participants will receive educational materials aimed at both patients and physicians to promote evidence-based deprescribing practices. The study compares outcomes between those receiving the intervention and those receiving standard care, focusing on PPI use, patient quality of life, and healthcare costs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Physicians will be eligible to participate if:

* They are prescribing PPIs in outpatient department of the study sites
* They have patients with potentially inappropriate PPI prescriptions

Patients will be eligible to participate if:

* They are ≥18 years
* They are presenting to out-patient departments of the study sites
* They have prescriptions of potentially inappropriate PPIs
* Their treating physicians are included in the study

Exclusion Criteria:

Physicians will be excluded if:

• They are involved in any other prescribing trial

Patients will be excluded if:

* They are unable to give informed consent, as judged by their physicians
* They have definitive indications for PPI use

Where it's running

• Ibrahim Bin Hamad Obaidullah Hospital
  Ras al-Khaimah, United Arab Emirates Recruiting

Study contacts

• Principal investigator: Syed Arman Rabbani — RAK Medical and Health Sciences University
• Study coordinator: Syed Arman Rabbani
• Email: arman@rakmhsu.ac.ae
• Phone: +971 7 2043000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding Patient Views on Reducing Medications in Advanced Cancer Care

  This study is trying to understand how patients with advanced cancer feel about reducing their medications to see what factors influence their thoughts on this process.

  Recruiting Nantes University Hospital · La Roche-sur-Yon and 7 other locations · NCT06193083

• Guiding the safe reduction of unnecessary proton pump inhibitors

  This study is testing a new way to help doctors safely reduce the use of unnecessary heartburn medications in patients to see if it works better than the usual approach.

  Recruiting University of Bern · Bern and 1 other locations · NCT06129474

• Collaborative GP-Pharmacist Approach to Tapering Benzodiazepines in Older Adults

  This study tests whether a GP-pharmacist collaboration and pharmacist-led motivational interviewing can help people aged 65 and older reduce or stop benzodiazepines prescribed for anxiety or sleep.

  Recruiting Nantes University Hospital · Nantes · NCT05765656

• Comparing Vonoprazan and oral PPIs for bleeding peptic ulcers

  This study tests whether a new medication called Vonoprazan is as good as standard proton pump inhibitors in preventing bleeding from peptic ulcers after treatment.

  Recruiting Phase 4 Chinese University of Hong Kong · Guangzhou, Guangdong and 7 other locations · NCT05582174

• e-ALIGN: Using the patient portal to align medicines with what matters most

  This project will see if sending education through the patient portal plus pharmacist-led medication reviews helps people 65 and older with mild cognitive impairment or dementia and their care partners reduce risky brain-active medicines.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07454824

• Proactive pharmacist e-consults to optimize lung health for people with HIV

  This trial tests whether proactive pharmacist-led e-consults can help people with HIV improve lung-health medications, vaccinations, smoking cessation, and deprescribing of certain inhaled medicines or PPIs.

  Recruiting Seattle Institute for Biomedical and Clinical Research · Boise, Idaho and 2 other locations · NCT07507435

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.